PROQR THERAPEUTICS N V revenue for the last year amounted to 178.33 M MXN, the most of which — 119.62 M MXN — came from its highest performing source at the moment, RNA Based Therapeutics, the year earlier bringing 82.75 M MXN. The greatest contribution to the revenue figure was made by United States — last year it brought PROQR THERAPEUTICS N V 119.62 M MXN, and the year before that — 82.75 M MXN.